EVS Glaucoma Therapeutics


Public lists: Eye Health (703)

EVS Glaucoma Therapeutics (EGT) is a Herndon-based spinout of Euclid Vision Systems that will develop a sustained delivery system for glaucoma medication. EGT will develop an implantable, bio-degradable, collagen-based drug delivery system for Latanoprost, the leading prescribed glaucoma medication. Latanoprost currently has a recommended daily dosing schedule. However, multiple studies indicate that glaucoma treatment failures result from improper dosing by 90 percent of patients taking Latanop...Show all

EVS Glaucoma Therapeutics (EGT) is a Herndon-based spinout of Euclid Vision Systems that will develop a sustained delivery system for glaucoma medication. EGT will develop an implantable, bio-degradable, collagen-based drug delivery system for Latano...Show all

Company (Alive / Active)

All investors data 1 Investors

Phone:

Fax:

2776 Towerview Road

 Herndon, 20171
 Virginia, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
EVS Glaucoma Therapeutics $0M Sep 11, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related EVS Glaucoma Therapeutics Jobs

jobs by Indeed job search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)